BACKGROUND: Studies regarding the role of iron on linear growth have yielded heterogeneous results. Some trials indicate that iron supplementation of iron-replete infants leads to slower-length gain. However, little is known of the relation between iron status and linear growth in school-age children. METHODS: We quantified plasma ferritin, mean corpuscular volume (MCV), and hemoglobin in 2714 children aged 5-12 years at recruitment into a cohort study. Height was measured periodically for a median of 30 months. Height-for-age Z-scores (HAZ) were calculated using the World Health Organization growth reference. Mixed effects models with restricted cubic splines were used to construct population HAZ-for-age growth curves for sex-and age-specific quartiles of each iron status indicator. RESULTS: Ferritin and MCV were each inversely related to attained HAZ among boys after the adjustment for baseline age, baseline body mass index-for-age Z-score and socioeconomic status. There was a decreasing monotonic relation between quartiles of ferritin and estimated change in HAZ from ages 6 to 14 years (P trend ¼ 0.001); boys in the 4th quartile experienced a HAZ change that was 0.46 Z lower than that of boys in the 1st quartile (P ¼ 0.0006). Similarly, we observed smaller HAZ change among boys in the highest quartile of MCV in comparison with those in the 1st quartile (P trend ¼ 0.001). Hemoglobin was not related to linear growth in boys. None of the iron-status indicators were associated with linear growth in girls. CONCLUSIONS: Higher iron status, as indicated by ferritin and MCV, is related to slower linear growth in iron-replete school-age boys.
INTRODUCTION
Iron is an essential micronutrient for child growth and development. The World Health Organization recommends iron supplementation in young children, a group that is at high risk for iron deficiency, due to an increased need for iron during periods of rapid growth. 1 In consequence, a large emphasis has been placed on the prevention of iron deficiency through prophylactic supplementation and food fortification. There are benefits to iron supplementation in deficient populations; however, unnecessary intake of iron may have adverse health implications for children who are not deficient. 2 Although iron is essential to many physiological processes, it also stimulates the production of free radicals and increases oxidative stress. 3 Thus, indiscriminate supplementation or intake of iron-fortified foods may impair normal cellular functions, and interfere with the absorption of other nutrients that are essential to growth and development. 4 Current literature regarding the effects of iron supplementation on linear growth in iron-replete populations is inconsistent and focused on childreno5 years of age. Three studies documented slower-length gain in iron-replete infants who received supplements, [5] [6] [7] while others found no effect of the supplementation on linear growth. [8] [9] [10] In an intervention study of well-nourished, ironsufficient Chilean infants, those who received iron supplements from 12-18 months of age were taller by the age 10 years than those who received the usual nutrition (controls). 11 These findings suggest that growth outcomes associated with iron status may not become apparent until later in childhood, yet, it is not known whether iron status during school years influences subsequent growth. Elucidating potential risks associated with high iron status has important implications in countries undergoing the nutrition transition, where there is increased consumption of iron-fortified food products. In Colombia, a Latin American country at the early stages of the nutrition transition, the prevalence of iron deficiency (ferritino12 mg/l) was 3.5% in 2010, whereas the prevalence of stunting (height-for-age Z-score, HAZo À 2) was 9%. 12 In this study, we examined the prospective association of three indicators of iron status, ferritin, mean corpuscular volume (MCV) and hemoglobin, with linear growth over a median of 2.5 years of follow-up in a representative cohort of iron-replete children from low-to-middle-income families in Bogotá, Colombia.
MATERIALS AND METHODS Subjects
This study was conducted in the context of the Bogotá School Children Cohort, a longitudinal investigation of health and nutrition among children from public schools in Bogotá, Colombia. Details of the study design have been previously reported. 13 Briefly, we recruited 3202 school children aged 5-12 years in February2006 from public schools in Bogotá, with the use of a random sampling strategy. The public school system enrolled 57% of all primary school children in Bogotá at the time, and 89% of them came from low-and middle-income socioeconomic backgrounds; 14 thus, the cohort is representative of these families.
At the time of enrollment, self-administered questionnaires were sent to parents to ascertain information on sociodemographic characteristics (82% response). In the proceeding weeks, trained research assistants visited the schools to obtain anthropometric measurements and a fasting blood sample from the children. Height was measured without shoes to the nearest 1 mm using a wall-mounted portable Seca 202 stadiometer (Seca, Hamburg, Germany), and weight was measured in light clothing to the nearest 0.1 kg on Tanita HS301 solar-powered electronic scales (Tanita, Tokyo, Japan) according to standard protocols. 15 Follow-up anthropometric measurements were obtained in June and November 2006, and once yearly thereafter by visiting the schools or homes of the children when they were absent from school on the day of assessment.
The parents or primary caregivers of all children gave written informed consent before enrollment into the study. The study protocol was approved by the Ethics Committee of the National University of Colombia Medical School; the Institutional Review Board at the University of Michigan approved the use of data from the study and exempted the analyses from review.
Laboratory methods
Phlebotomists obtained B4 ml of venous blood from the children after an overnight fast. Samples were collected in EDTA tubes and transported the same day, on ice and protected from sunlight, to the National Institute of Health in Bogotá. MCV and hemoglobin were determined as part of a complete blood count; hemoglobin levels were quantified using a hemiglobincyanide method. Plasma ferritin concentrations were determined using competitive chemiluminescent immunoassay in an ADVIA Centaur analyzer (Bayer Diagnostics, Tarrytown, NY, USA). C-reactive protein (CRP) was measured with the use of a turbidimetric immunoassay on an ACS180 analyzer (Bayer Diagnostics).
Data analysis
Specimens were collected in 2816 (88%) children, and results of iron status biomarkers were available in 2813. Of them, 2714 children also had a height measurement at baseline and at least one measurement during follow-up; they constituted the final population for this study. No exclusions were made based on iron status, as the aim of this study was to assess the relation between iron status and linear growth in a population-based study representative of all public school children in the city of Bogotá. The study population did not differ from those who were not included in terms of socioeconomic or anthropometric characteristics at the time of recruitment.
We first compared the distribution of each iron status indicator (ferritin, MCV and hemoglobin) by child and maternal characteristics to identify variables that may confound the associations of these markers with the anthropometric outcome. Children's body mass index (BMI)-for-age and HAZ were calculated with the use of the sex-specific growth references for children [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] years from the World Health Organization. 16 Maternal BMI was calculated from measured height and weight in 26% of the mothers and from self-reported data otherwise. Maternal weight status was classified according to BMI categories as underweight (o18.5), adequate (18.5-24.9) , overweight (25.0-29.9) or obese (X30). 17 Household socioeconomic status corresponded to the government's classification assigned to each household for tax and planning purposes. The statistical significance of these associations was tested with use of linear regression models, with each iron status indicator as the outcome. For ordinal characteristics, we obtained a test for linear trend.
Next, we examined associations of baseline ferritin, MCV and hemoglobin with the outcome of interest, HAZ change, over the followup separately for boys and girls. We estimated average HAZ-for-age growth curves for sex-and age-specific quartiles of each iron status indicator using mixed-effect models for repeated measurements with restricted cubic splines according to previously published methods. 18 Cubic splines represent nonlinear terms for the distribution of age-atassessment that allow smoothing of nonlinear changes in HAZ over time. The cubic spline function consists of piecewise cubic polynomials that are smoothly joined at joint points or 'knots'. 19 It is 'restricted' because the polynomials at the tails are constrained to be linear. In these analyses, knots were placed at 5.5, 10 , 13 and 14.5 years, because these ages seem to be relevant points in curvilinear portions of the height-for-age growth reference for children 5-19 years. 16 In the spline models, the outcome was HAZ, and the predictors included sex-and age-specific quartiles of each iron status indicator, linear and spline terms for child age-at-assessment in decimal years, and interaction terms between quartiles of the iron status indicator and the child age terms. Random effects for the intercept and the linear term for age were included to account for the within-child correlation of repeated height measurements in the estimation of the variance. 20 We also accounted for within-family correlations among siblings in the cohort by introducing a random effect for family into the models. As these methods do not require an equal number of measurements, or that measurements be obtained at the same time for all participants, all available measurements were included in the models. From the growth curves of children in each quartile of the iron-status indicators, we estimated change in HAZ from 6 to 14 years as the primary outcome of interest. We then calculated adjusted differences and 95% confidence intervals in HAZ change between age-adjusted quartiles of each iron status indicator.
In the adjusted analyses, we considered covariates that were associated with the iron-status indicators in the univariate analyses at Po0.10, as well as those that are known predictors of child growth. Adjusted differences and 95% confidence interval were estimated by introducing into the mixed models covariates that included baseline age, baseline BMI-for-age Z-score and socioeconomic status. The models with ferritin as the exposure also included a continuous indicator variable for natural log-transformed CRP because, as an acute phase reactant, high ferritin can also represent inflammation. Further adjustment for maternal BMI did not change the direction, magnitude or statistical significance of the associations. In all models, empirical estimates of variance were used to overcome deviations from the multivariate normality assumption. Because the age distribution of children at baseline ranged from 5 to 12 years, we tested for possible birth cohort effects in the construction of the growth curves by including an interaction term between baseline age and age-adjusted quartiles of each iron status indicator. The interaction terms provided no evidence of birth cohort effects.
All analyses were carried out with the use of the Statistical Analyses System software (version 9.2; SAS Institute Inc., Cary, NC, USA).
RESULTS
At the time of recruitment, mean ± s.d. age was 8.8 ± 1.8 years; 50.2% of the children were male. Mean HAZ at baseline was À 0.80±0.95 Z for boys and À 0.77±1.02 Z for girls. Mean±s.d. ferritin, MCV and hemoglobin were 41.4 ± 23.4 mg/l, 85.5 ± 5.3 fl and 14.5 ± 1.2 g/dl, respectively for boys, and 42.9 ± 23.0 mg/l, 86.6±5.2 fl and 14.5±1.1 g/dl, respectively, for girls. The correlations (Spearman's Rho) between ferritin and hemoglobin, ferritin and MCV and hemoglobin and MCV were 0.08, 0.09, and À 0.16, respectively. Only 1.6% of the study population had CRP concentrations higher than the clinical cut-point for infection (10 mg/dl). 21 Median follow-up time (difference between last and first assessments for each child) was 2.5 years (interquartile range: 2.1, 2.6 years), during, which each child contributed a median of four height measurements. There were a total of 10 711 measurements with the following distribution by age:o6 years, 331; 6 too8 years, 1577; 8 too10 years, 3433; 10 too12 years, 3794; 12 too14 years, 1437; and 14-17 years, 139.
At baseline (Table 1) , all three indicators of iron status were positively associated with age. HAZ and BMI-for-age Z, were each positively associated with ferritin and hemoglobin, whereas MCV was inversely related to BMI-for-age Z and maternal education. There was a positive relation of maternal BMI with ferritin and hemoglobin. Household socioeconomic status was inversely related to MCV, but positively associated with hemoglobin.
Next, we estimated average HAZ growth curves for quartiles of each iron status indicator separately for boys and girls (Figure 1 ). In the unadjusted analysis, we observed a decreasing monotonic relation of ferritin and MCV quartiles with change in HAZ during follow-up (P trend ¼ 0.004 and P trend ¼ 0.0006, respectively) among boys. These associations remained significant in the multivariable analysis (P trend ¼ 0.001 for both ferritin and MCV). After the adjustment for baseline age, baseline BMI-for-age Z-score, and socioeconomic status, estimated change in HAZ from 6 to 14 years was 0.46 Z lower for boys in the highest quartile of ferritin, compared with boys in the lowest quartile (P ¼ 0.0006; Table 2 ). Similarly, estimated HAZ change from ages 6 to 14 years was 0.39 Z lower in boys in the highest quartile of MCV, compared with boys with lowest MCV at baseline (P ¼ 0.004). Hemoglobin was not associated with HAZ change in boys. None of the indicators were significantly related to HAZ change among girls (data not shown).
DISCUSSION
In this longitudinal investigation of school-age children, we estimated mean HAZ change between 6 and 14 years with respect to quartiles of three iron-status indicators, plasma ferritin concentrations, MCV and hemoglobin, using population-level growth curves constructed from repeated measurements of height. We found that higher ferritin and MCV were both related to a lower mean change in HAZ during follow-up among boys.
Participants in this cohort are iron-replete, with a 3.3% prevalence of iron deficiency. 22 Mean ferritin concentration at baseline was 41.9 ± 23.1 mg/l, which is B6 mg/l higher than reported values for British children 4-18 years, 23 and 13 mg/l higher than reported values for children 3-5 years, and nonpregnant females 12-19 years in the US. 24 Although plasma ferritin can be elevated during acute infection, only 1.6% of the study population had CRP concentrations higher than the clinical cut-point for infection. 21 Neither exclusion of these children nor additional adjustment for CRP in the analysis changed the direction, magnitude or statistical significance of the results; thus, ferritin levels are likely an accurate reflection of iron status of this population. Possible explanations to the high iron status of these children include their exposure to a national wheat flour fortification program ongoing since 1996 and a school snack program existing since 2004 in Bogotá, both of which provide additional dietary iron. 13 The associations of ferritin and MCV with HAZ change suggest that more iron is not necessarily related to better linear growth in an iron-replete population.
Our finding of an inverse relation between iron status and linear growth is consistent with results from intervention studies conducted in younger children. A randomized-controlled trial conducted among breast-fed Swedish and Honduran infants showed that iron supplementation adversely affected linear growth in non-deficient individuals. 5 Among Swedish infants, gains in length and head circumference were significantly lower in those who received iron than in those given placebo from 4 to 9 months. The same effect on length was observed in non-anemic Honduran infants who received supplements from 4 to 6 months. Age, y Q1 Q2 Q3 Q4
Height-for-age z-score Figure 1 . Height-for-age Z-score curves according to age-specific quartiles of ferritin, MCV and hemoglobin. The growth curves were built using mixed effects models for repeated measurements with restricted cubic splines. The solid gray line represents the growth curve for children in the 1st quartile of each iron status indicator; the dashed gray line represents children in the 2nd quartile of each iron status indicator; the dashed black line represents children in the 3rd quartile of each iron status indicator; the solid black line represents children in the 4th quartile of each iron status indicator.
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Similarly, in a randomized placebo-controlled trial among 50 iron-deficient and 100 iron-replete Indian children 6-24 months of age, investigators reported that iron therapy, as compared with placebo, resulted in significantly larger mean monthly weight and length gains in the iron-deficient group, but in significant decreases in both growth parameters among iron-sufficient children. 6 A recent cohort study of healthy Italian infants found that breast-fed babies who did not receive iron supplementation had significantly higher length-for-age than those who received iron-fortified foods or oral iron supplementation. 7 In the present study, boys with the lowest ferritin or MCV at the time of recruitment experienced the greatest increase in HAZ between 6 and 14 years. The average difference in HAZ change of À 0.46 Z between extreme quartiles of ferritin would roughly correspond to 2.7 cm. We noted that estimated HAZ of boys in the 1st quartile of ferritin was significantly lower than that of boys in the 4th quartile by age 6. Because ferritin is an indicator of body iron stores 25 that can be inversely related to linear growth, 26 as iron needs are increased during periods of rapid growth, it is possible that boys with low ferritin were experiencing catch-up growth and were growing at a faster velocity before recruitment into the cohort. However, we observed a similar inverse relation with MCV that cannot be explained with this reasoning. Unlike the trend with ferritin, HAZ was not significantly different between boys in the first and fourth quartiles of MCV by age 6, yet those in the lowest quartile grew the fastest over follow-up. The average difference in HAZ change of À 0.39 Z between children in extreme quartiles of MCV would roughly correspond to a 2.5 cm difference. In addition, MCV is not an indicator of iron stores; MCV is related to erythropoiesis, and is a measure of circulating iron based on red blood cell size, so the inverse association cannot be attributed to depletion of storage iron.
There are a few mechanisms that could explain the observed associations. Although iron has an important role in many physiologic processes, including oxygen transport and oxidation of lipids and proteins, 27 it also stimulates the production of free radicals and increases oxidative stress. 28 It is possible that iron causes toxic effects when absorbed in excess, as oxidative stress affects cellular cytokine responses, which can lead to alterations in gene expression of growth factors, thereby reducing growth. 28 Iron excess may also contribute to greater risk of infection if the pathogens have access to more free iron for their own growth and reproduction. 29 Finally, a surplus of iron may hinder growth by impeding absorption of other essential nutrients that are necessary to growth and development. 4 We found that the association between iron status and growth was apparent only in boys. In one study of healthy Italian infants, in which iron was inversely related to linear growth, no sex differences were reported. 7 Other previous investigations did not present sex-specific associations. In our study, the fact that iron status was related to growth in boys only could be due to sex differences in growth patterns during the age range examined. Girls begin their adolescent growth spurt at B10.5 years, with linear growth velocity at its peak around 12 years. 30 Large between-individual variability in development during adolescence could have obscured associations between iron status and linear growth. On the other hand, growth velocity acceleration in boys occurs roughly 2 years later than girls, and does not peak until around 14 years, 30 making the adolescent growth spurt less likely to have influenced the HAZ curves.
Of note, we did not observe any significant associations between hemoglobin and growth outcomes for either sex. Although hemoglobin is a widely-used parameter for diagnosing iron-deficiency anemia and assessing hematological response to interventions, it may not be an informative indicator of iron status in non-anemic populations. The prevalence of anemia (hemoglobino12.7 g/dl) in the Bogotá School Children Cohort was only 3.7%; 31 hemoglobin levels were weakly correlated with plasma ferritin concentrations and MCV. Iron is primarily absorbed in the duodenum and can be stored intracellularly as ferritin until needed, or transported basolaterally to plasma for hemoglobin production in response to iron-deficiency anemia. 32 Under conditions of adequate iron status, hemoglobin levels should remain relatively stable, as absorbed iron is stored in ferritin, rather than used in hemoglobin production. This reasoning is supported by intervention studies conducted Values are mean ± s.e. Estimates are from growth curves built using mixed effects models with restricted cubic splines that accounted for within-child repeated height measurements. An exchangeable correlation structure was specified to account for within-family correlations.
c Differences in change and 95% CI are adjusted for baseline age, baseline BMI-for-age Z-score and socioeconomic status. The model for ferritin was additionally adjusted for plasma C-reactive protein. Iron status and linear growth W Perng et al in infants 9 and pregnant women 33 , which found no difference in hemoglobin concentrations following supplementation among non-iron-deficient individuals Although there is limited literature on the relation of hemoglobin status with height in iron-replete populations, a recent cohort study conducted in non-iron-deficient Italian infants provided no evidence of a clear association between hemoglobin status and length gain between 6 and 24 months. 7 Our study has several strengths. Blood samples were collected from a large and representative sample of children, and valid biomarkers were measured to determine iron status. The prospective design and use of repeated and standardized height measurements enhanced our ability to explore the temporal relation between markers iron status and linear growth. We used modern analytic methods to model nonlinear growth curves, and adjusted the sex-specific estimates of association for key potential confounders, including baseline age, baseline BMI-for-age Z-score and socioeconomic status. The study has some limitations. First, we relied on only one measurement of the iron-status indicators at the time of enrollment as the primary exposure, and lacked information on factors affecting iron status during follow-up. However, there is some evidence suggesting that one measure of iron-status indicators may be a reasonable proxy for long-term exposure in other populations. 34, 35 Second, we may not have completely captured the influence of inflammation on ferritin levels by adjusting for CRP only. Yet, associations with MCV, an inflammation-independent marker of iron status, were consistent with those for ferritin. Third, anthropometric measures are subject to random error; nevertheless, intra-and inter-observer coefficients of variation for height measurements in our study were very low. Fourth, we lacked assessments of sexual development staging, which might affect both iron status and linear growth. Finally, generalizability of the findings to populations with higher prevalence of iron deficiency may be limited.
We conclude that higher iron status, as indicated by plasma ferritin concentrations and MCV, is related to slower linear growth in iron-replete school-age boys. Cohort studies examining the association of iron status with linear growth are required to elucidate long-term growth outcomes related to excess iron. These findings raise concern about iron-related interventions implemented in developing countries to counter the dual burden of malnutrition and overweight, and point toward the importance of carefully monitoring iron status and child growth in these settings. Future studies are warranted to formally assess the efficacy and safety of iron fortification or supplementation programs on growth and developmental outcomes among ironreplete children.
